Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2025-11-11 Investor Presentation
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a notice about the scheduling and details of a corporate investor relations (IR) presentation event, including date, time, location, participants, purpose, and contact information. It does not contain financial statements or detailed financial analysis but rather announces the occurrence of an investor presentation event. Therefore, it fits the category of Investor Presentation (IP). The document length is short and it is not a report publication announcement or a regulatory filing. Hence, the classification is Investor Presentation (IP) with high confidence.
2025-11-11 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'MedPacto' (메드팩토) for the period ending June 30, 2025. It contains detailed financial information, business operations, management discussions, and corporate governance details, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, but the full report itself. H1 2025
2025-08-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a regulatory filing under the RNS category, as it does not fit into specific categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2025-07-31 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2025-07-17 Korean
투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상, 공개시험 결과)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory filing from MedPacto submitted to the Korea Exchange (KRX). It details the results of a clinical trial (Phase 1b/2a for NSCLC treatment). In the context of Korean regulatory filings (DART/KIND), this type of disclosure regarding clinical trial results is classified as a 'Regulatory Filing' (RNS) as it serves as a mandatory public disclosure of material business information that does not fit into specific categories like financial reports or shareholder meeting materials.
2025-06-11 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for MedPacto, covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business operations, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.